Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients
Clinical trial NCT04381871 · UNKNOWN
Trial details
- NCT number
- NCT04381871
- Sponsor
- Al-Neelain University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2020-08-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.